Study of #realworldevidence in patients treated with palbociclib during a 2.5 Years follow-up period (NCT05135104)
We are excited to announce our new clinical study project in collaboration with Principal Investigator Dr. Cristina Oprean – Oncologist and the Oncology Department from Oncohelp Outpatient Unit Timisoara.
This retrospective, real-world evidence study will identify pathological and clinical features of metastatic breast cancer that are associated with Palbociclib best efficacy, measured by overall response rate, progression free survival and overall survival during a 2.5 years follow-up.